Compatibility mechanism of Qishen Yiqi Dripping Pills for treatment of myocardial ischemia based on UPLC-Q-Exactive Orbitrap-MS and network pharmacology
Clinical efficacy and mechanism of Qishen Yiqi Dripping Pills(QSYQ)have been well researched,but the compatibility mechanism underlying its therapeutic effect still requires further analysis.This study aims to explore the compatibility mechanism of QSYQ in treating myocardial ischemia.UPLC-Q-Exactive Orbitrap-MS technique was used to obtain the absorbed blood components of QSYQ.Target proteins of the absorbed components were collected and screened using TCMSP,TCMIP,and SwissTargetPrediction da-tabases.Disease proteins related to myocardial ischemia were obtained through GeneCards,OMIM,and DisGeNET databases.Core targets and core components were obtained using online plotting software Venny 2.1.0,STRING,and Cytoscape 3.9.1 software.David database was used for GO functional annotation and KEGG pathway enrichment of core targets,obtaining the main pathways of QSYQ in treating myocardial ischemia and drawing visualized network diagrams.The compatibility mechanism was analyzed based on"compo-nent-target","drug-pathway",and"PI3K-AKT"characteristic pathways,and molecular docking was used for validation.This study obtained 42 absorbed blood components of QSYQ,556 component targets,1 980 disease targets,69 core targets,and 15 core compo-nents.QSYQ can exert therapeutic effects on myocardial ischemia by regulating proteins such as MAPK1,RELA,SRC,JUN,and STAT3,acting on signaling pathways such as HIF-1,PI3K-AKT,Toll-like,MAPK,VEGF,etc.The interaction network diagrams of"component-target"and"drug-pathway"preliminarily elucidated the synergy among the four drugs in this prescription at the level of targets and pathways.The PI3K-AKT characteristic pathway indicated that the sovereign drug Huangqi(Astragali Radix)and minister drug Danshen(Salviae Miltiorrhizae Radix et Rhizoma)could regulate most targets in this pathway,while the assistant drug Sanqi(No-toginseng Radix et Rhizoma)cooperated with Huangqi and Danshen on IL6 and AKT proteins,and the envoy drug Jiangxiang(Dalber-giae Odoriferae Lignum)acted on AKT and RXRA proteins,with all drugs acting synergistically on proteins such as AKT,RXRA,NFKB to regulate cell survival and promote angiogenesis.Molecular docking indicated that hydrogen bonding and hydrophobic interac-tions might be the main forms of action,also validating the distribution of binding energy of the PI3K-AKT signaling pathway.This study analyzed the compatibility connotation of QSYQ from multiple dimensions including drugs,components,targets,and pathways,providing reference basis for the study of the mechanism of action and compatibility rules of QSYQ.
NETL
NSTL
万方数据
